详细信息
Clinical Application of Traditional Chinese Medicine Therapy for Type 2 Diabetes Mellitus: An Evidence Map ( SCI-EXPANDED收录) 被引量:6
文献类型:期刊文献
英文题名:Clinical Application of Traditional Chinese Medicine Therapy for Type 2 Diabetes Mellitus: An Evidence Map
作者:Wang, Ying[1];Dai, Zelei[2];Wang, Qin[3];He, Ying[4];Peng, Yalan[5];Wu, Miaomiao[6,7];Song, Haiqi[6,7];Ma, Long[8];Zhang, Yonggang[9,10];Li, Nian[1]
第一作者:Wang, Ying
通信作者:Li, N[1];Zhang, YG[2];Zhang, YG[3]
机构:[1]Sichuan Univ, West China Hosp, Dept Med Adm, Chengdu 610000, Peoples R China;[2]Sichuan Univ, Canc Ctr, West China Clin Sch Med, Dept Head & Neck Oncol, Chengdu 610041, Peoples R China;[3]Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu 610041, Peoples R China;[4]Sichuan Univ, West China Hosp, Dept Integrated Tradit & Western Med, Chengdu 610041, Peoples R China;[5]Sichuan Univ, Hosp Infect Control Dept, West China Hosp, Chengdu 610041, Peoples R China;[6]Sichuan Univ, West China Hosp, Int Med Ctr, Dept Gen Practice, Chengdu 610041, Peoples R China;[7]Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Int Med Ctr, Chengdu 610041, Peoples R China;[8]Gansu Univ Chinese Med, Clin Med Coll 1, Lanzhou 730000, Peoples R China;[9]Sichuan Univ, West China Hosp, Dept Period Press, Chengdu 610041, Peoples R China;[10]Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Peoples R China
第一机构:Sichuan Univ, West China Hosp, Dept Med Adm, Chengdu 610000, Peoples R China
通信机构:[1]corresponding author), Sichuan Univ, West China Hosp, Dept Med Adm, Chengdu 610000, Peoples R China;[2]corresponding author), Sichuan Univ, West China Hosp, Dept Period Press, Chengdu 610041, Peoples R China;[3]corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Peoples R China.
年份:2022
卷号:2022
外文期刊名:EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
收录:;Scopus(收录号:2-s2.0-85135291887);WOS:【SCI-EXPANDED(收录号:WOS:000890991400001)】;
基金:AcknowledgmentsThis study was funded by the National Natural Science Foundation of China (No. 82004213) and the Project of Sichuan Provincial Department of Science and Technology (No. 2021YFH0191).
语种:英文
摘要:Type 2 diabetes mellitus (T2DM), a common disease with a complex etiology in the world, is an important risk factor for severe cardiovascular and cerebrovascular diseases. However, treatments of T2DM are mainly based on Western medicine, whose severe side effects make traditional Chinese medicine (TCM) therapy more appealing to patients and clinicians. The overall clinical evidence for different TCM therapies in the treatment of T2DM is still unclear. This study aimed to adopt the evidence-mapping method and integrate the evidence from various researches on this topic, to depict the whole picture of TCM therapies for T2DM. This review included searches of PubMed, Embase, Web of Science, and three major Chinese literature databases (CNKI, VIP, and Wanfang) from inception to November 18, 2021. Two independent reviewers screened the literature, extracted information, and evaluated the quality of all included studies. A systematic review was subsequently performed. In total, 47 studies were reviewed, of which 46 studies (97.9%) were from China and 1 (2.1%) was from Canada. The evidence map was conducted according to different TCM therapies, including herbs or herbal extracts, compounds, powders, decoctions, pills, external treatment, basic theories and treatment principles of TCM, proprietary Chinese medicines, and unspecified TCM integrated therapies. According to the AMSTAR-2 scoring results, 4 papers were rated as high quality, 11 were low quality, and 32 were very low quality. Outcome indicators mainly focused on FBG, HbA1c, 2-h PBG, TC, TG, LDL-C, etc. The results showed that different types of TCM treatment had different improvement effects on the outcome indicators of T2DM. More consistent benefits were observed in the improvement of FBG, HbA1c, and 2-h PBG with treatment regimens based on basic theories and treatment principles of TCM, decoctions and pills, and unspecified TCM integrated therapies. Among herbs, ginger and Coptis root showed more improvement in all outcomes. Compounds, powders, and external treatment showed relatively consistent beneficial effects on the improvement of FBG. No serious adverse events were reported. Overall, the current evidence map provided an intuitive overview of the beneficial effects of TCM therapies in the treatment of type 2 diabetes. This study can be used as a reference for the clinical application of traditional Chinese medicine in T2DM, but due to the low-quality level of the included studies, it should be treated with caution in clinical practices.
参考文献:
正在载入数据...